StockData
Bristol Myers Squibb Co logo

Bristol Myers Squibb Co (BMY) stock

BMYNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as CELG.RI
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 14/3029% below fair value
$61.35−1.58 (-2.51%)

Close on Nov 17, 2026Market cap $125.40BP/E 13.6Yield 4.06%

Bristol Myers Squibb ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

No ebitda figures for Bristol Myers Squibb

Bristol Myers Squibb has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Bristol Myers Squibb figures

See a number that looks wrong?